Retatrutide

Retatrutide (LY3437943) is a synthetic research peptide that acts as a triple receptor agonist, targeting the GLP-1, GIP and glucagon receptors. Evolve Peptides supplies it as lyophilized powder in 5 mg, 10 mg, 12 mg, 15 mg, 20 mg, 30 mg and 60 mg vials.

Every lot is third-party tested for identity and purity (99%+), and the certificate of analysis is shown on each product page. Orders ship from the U.S.

Retatrutide vial sizes

What is Retatrutide?

Retatrutide is a lab-engineered compound built to replicate and extend the activity of three hormones involved in energy regulation, glucose metabolism and appetite control. Because it binds the GLP-1, GIP and glucagon receptors together, researchers can study several connected hormonal pathways in a single model. Semaglutide covers the GLP-1 receptor alone, and Tirzepatide covers GLP-1 and GIP.

It is the focus of ongoing non-clinical and preclinical studies on metabolic signaling. The mechanism overview, references and current lot documentation are on each size’s page: Retatrutide 5 mg, Retatrutide 10 mg, Retatrutide 12 mg, Retatrutide 15 mg, Retatrutide 20 mg, Retatrutide 30 mg, Retatrutide 60 mg.

Research use only. Retatrutide from Evolve Peptides is intended for laboratory research. It is not intended for human consumption, therapeutic use or diagnostic procedures.

Bestsellers:
SHOPPING BAG 0
RECENTLY VIEWED 0
Join Waitlist Enter your email address to be notified when this item is back in stock.
Evolve Peptides vials: BPC-157 + TB-500, GLP-2 TZ and GLP-1 S

Get 10% Off Your Next Order

Enter your email and we’ll send your code.

For research use only. Unsubscribe any time.

Check Your Inbox

Your 10% code is on its way.

Added to wishlist! VIEW WISHLIST